Skip to main navigation
Skip to main content
KASL
Contact us
mobile search button
mobile menu button
Search
Advanced Search
ABOUT
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
CMH Guidelines for reviewers
Checklist
E-submission
Copyright transfer agreement
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
CMH Guidelines for reviewers
Checklist
E-submission
Copyright transfer agreement
Page Path
HOME
Search
Haifeng He
WHERE t1.sid in(parameter_dbtbl_author like '%Haifeng He%') and t1.xml_status <> 99
1
results for
"Haifeng He"
Filter
Article category
Letter to the Editor (1)
Keywords
Clinical trial (1)
HK-660S (1)
Primary sclerosing cholangitis (1)
Publication year
2026 (1)
Keywords
Clinical trial (1)
HK-660S (1)
Primary sclerosing cholangitis (1)
Cancel
Close
Publication Year
2026 (1)
Cancel
Close
Funded articles
Cancel
Close
"Haifeng He"
Letter to the Editor
Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangitis: Letter to the editor on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”
Yizi He, Haifeng He, Qi Liang, Yongzhi Xie
Clin Mol Hepatol
2026;32(1):e1-e3.
Published online March 17, 2025
DOI:
https://doi.org/10.3350/cmh.2025.0239
PDF
6,117
View
69
Download
First
Prev
Page
of 1
Next
Last
×
TOP